Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAF1 | P21675 | 1/20 | 0.43 |
| ▸ | HTR3E | A5X5Y0 | 8/20 | 0.40 |
| ▸ | HTR3B | O95264 | 8/20 | 0.40 |
| ▸ | HTR3A | P46098 | 8/20 | 0.40 |
| ▸ | HTR3D | Q70Z44 | 8/20 | 0.40 |
| ▸ | HTR3C | Q8WXA8 | 8/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5046677 | 0.90 | LMNA (0.45) | TAF1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL13264361 | 0.87 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2LMNAKCNH2MCHR1 | |
| SCHEMBL12002254 | 0.87 | KCNH2 (0.43) | LMNAKCNH2MCHR1 | |
| SCHEMBL2796318 | 0.87 | LMNA (0.41) | TAF1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL12002158 | 0.86 | KCNH2 (0.43) | ALDH1A1SMN1; SMN2TSHRMAPK1LMNA | |
| SCHEMBL12000213 | 0.85 | KCNH2 (0.48) | TAF1HTR3EHTR3BHTR3AHTR3D | |
| Hydrochloric Acid SCHEMBL2799164 | 0.84 | KCNH2 (0.48) | TAF1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL5044720 | 0.82 | UBE2M (0.44) | ALDH1A1SMN1; SMN2TSHRMAPK1MAPK10 | |
| SCHEMBL5046667 | 0.81 | UBE2M (0.44) | TAF1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL13264442 | 0.81 | KCNH2 (0.45) | SMN1; SMN2LMNACNR1KCNH2MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120214990-A1 | QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214990-A1 | QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION | NQO2, ASNS, NDUFS1 | TAF1 2812/4885HTR3E 4654/4885HTR3B 4505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.